MARKHAM, ON -- (MARKET WIRE) -- September 12, 2006 -- AlphaRx Inc. (OTCBB: ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application entitled "Stabilization of Benzoyl Peroxide in Solution."
